NeuroPace, Inc. (NPCE) Stock Forecast
NPCE analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.90 / 5 from 10 analysts
- Price target
- $20.00 average of analyst targets
- Upside to target
- +63.4% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $-0.14
- 52-week range
- $9.40 – $19.29
NPCE analyst ratings
10 analystsNumber of analysts at each rating.
NPCE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NPCE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.15 | −$0.05 | −$0.11 | +21.6% | 8 |
| Current fiscal year (2026) | −$0.43 | −$0.67 | −$0.35 | −$0.66 | +34.3% | 9 |
| Next fiscal year (2027) | −$0.22 | −$0.45 | $0.09 | −$0.43 | +49.9% | 9 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NPCE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $27.1M | $26.2M | $27.8M | −0.9% | 10 |
| Current fiscal year (2026) | $100.3M | $99.5M | $101.1M | +0.3% | 10 |
| Next fiscal year (2027) | $122.4M | $116.0M | $125.5M | +22.1% | 10 |
NPCE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NPCE revenue: reported and forecast
NPCE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.10 | −$0.09 | −$0.09 | −$0.09 | −$0.09 | −16.2% | 3 up · 2 down |
| Current fiscal year (2026) | −$0.56 | −$0.45 | −$0.44 | −$0.43 | −$0.43 | −22.6% | 7 up · 0 down |
| Next fiscal year (2027) | −$0.30 | −$0.22 | −$0.22 | −$0.22 | −$0.22 | −26.8% | 4 up · 3 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NPCE earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NPCE beat in 11 of 12.
What analysts expect from NPCE
10 analysts cover NeuroPace; their consensus rating is strong buy (4.90 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.00, 63.4% above the latest close of $12.24. Analysts expect earnings of −$0.43 per share for 2026, +34.3% from a year earlier. For 2027 the average estimate is −$0.22 per share on revenue of $122.4 million. NeuroPace beat the EPS estimate in 11 of the last 12 quarters.
Related: NPCE income statement, NPCE key metrics, NPCE chart. See the NPCE stock overview for the latest quote and news.
NPCE forecast FAQ
What is NeuroPace's price target?
The average analyst price target for NeuroPace is $20.00, 63.4% above the latest close of $12.24.
Is NeuroPace a buy, hold or sell?
Of 10 analysts covering NeuroPace, 9 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is NeuroPace's EPS forecast?
Analysts forecast −$0.43 per share for 2026 (range −$0.67 to −$0.35); for 2027 the estimate is −$0.22.
What is NeuroPace's revenue forecast?
The average revenue estimate for 2026 is $100.3 million, growth of 0.3%; for 2027 it is $122.4 million.
When does NeuroPace report earnings?
NeuroPace is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $-0.14.
Does NeuroPace usually beat earnings estimates?
NeuroPace reported EPS at or above the analyst estimate in 11 of the last 12 quarters.